Envolizumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Envolizumab, covering 2022-06-14 to 2025-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC [Phase 2]